ClinicalTrials.Veeva

Menu

Late In-the-bag intraOcular Lens dislocatioN Surgery (LION)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Unknown

Conditions

Intraocular Lens Dislocation

Treatments

Procedure: IOL exchange
Procedure: IOL repositioning

Study type

Interventional

Funder types

Other

Identifiers

NCT03276104
2017/5506

Details and patient eligibility

About

Overall aim of the study is to compare the safety and efficacy of two different surgical methods to treat Late In-the-bag intraocular lens dislocation.

Full description

Cataract is a condition of unclear lens that cause poor vision. The only treatment is surgery where the blurred biological lens is replaced with an artificial clear lens (IOL). Most people who operate achieve full vision. Nevertheless, serious complications may occasionally occur, and one of these is dislocation of the entire complex with IOL and lens capsule. This requires surgical treatment.

In this study the investigators want to compare two different surgical methods used in late dislocation of IOL inside the capsule after cataract surgery. Patients will be randomly affiliated to either the suturing of existing IOL / capsule complex, or lens exchange to an IOL fixed to the iris.

The focus of the trial will be especially on complications and other eye changes in the early stages of surgery. Today, little data is available on these topics, and the investigators believe that new knowledge can bring us closer to a response to preferred operating techniques and an optimal drug drop regime for the patient group.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IOL inside the capsule ("in-the-bag")
  • Late dislocation (more than 6 months after cataract surgery)
  • IOL visible in the pupillary area in the supine position and hence possible to perform surgery with an anterior approach
  • Eligibility for both operation methods
  • Ability to cooperate fairly well during the examinations
  • Willing to participate in the study, e.g. willingness to participate at all control visits

Exclusion criteria

  • IOL designs that cannot be repositioned with a suture loop, such as plate-haptic IOLs without holes in the peripheral part
  • Eyes with especially thin sclera
  • Active uveitis or pronounced iris pathology
  • Eyes with previously performed Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)
  • Totally dislocated IOL into the posterior segment of the eye requiring pars plana vitrectomy
  • Eyes that prior to cataract extraction had a subluxated lens in need of surgery with a Cionni capsular tension ring (e.g. patients with Marfan syndrome and ectopia lentis)
  • Cases requiring a change in refraction. Risk of severe anisometropia
  • Patients unable to lie in supine position for surgery in local anesthesia, e.g. severe chronic obstructive pulmonary disease and severe heart failure
  • Patients using anticoagulants that cannot be discontinued

For patients with dislocated IOLs in both eyes during the study period, only the first operated eye will be included. Patients without prospects of improvement in vision will be excluded.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

IOL repositioning group
Active Comparator group
Treatment:
Procedure: IOL repositioning
IOL exchange group
Active Comparator group
Treatment:
Procedure: IOL exchange

Trial contacts and locations

1

Loading...

Central trial contact

Marius Dalby, M.D. PhD Cand.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems